Morgan Stanley
MDLN

Morgan Stanley’s Medline Inc MDLN Stock Holding History

Morgan Stanley’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852M Buy
21,605,662
+5,902,759
+38% +$238M 0.05% 374
2026
Q1 		$699M Buy
15,702,903
+540,843
+4% +$23.9M 0.04% 418
2025
Q4 		$637M Buy
+15,162,060
New +$640M 0.04% 448

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley's MDLN Position: Q2 2026 in Review

Morgan Stanley increased its Medline Inc (MDLN) stake by 38% in Q2 2026, buying an estimated $238M and bringing the position to 21,605,662 shares worth $852M. The position accounts for 0.05% of the portfolio, ranked #374.

Morgan Stanley first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Morgan Stanley held 21,605,662 shares of Medline Inc worth $852M as of Q2 2026.
  • Morgan Stanley bought 5,902,759 Medline Inc shares in Q2 2026, an estimated $238M.
  • Medline Inc made up 0.05% of Morgan Stanley's portfolio in Q2 2026, its #374 holding.
  • Morgan Stanley first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.